Market research
CVSG.LSE CVS Group plc
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 880M
- P/E ratio
- 56.17
- Analyst target
- 1666.5001
- Dividend yield
- 0.7%
- Beta
- 1.07
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- GB00B2863827
- Market cap
- 880M
- P/E ratio
- 56.17
- Analyst target
- 1666.5001
- Dividend yield
- 0.7%
- Beta
- 1.07
About
About CVS Group plc
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products, as well as an online dispensary. In addition, the company provides veterinary instrumentation supply and property development services. The company was founded in 1999 and is headquartered in Diss, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the CVSG.LSE discussion.
5 years, 5 months ago
CVS Group plc is currently in a long term uptrend where the price is trading 36.2% above its 200 day moving average.
From a valuation standpoint, the stock is 38.9% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 2.9.
CVS Group plc's total revenue sank by 0.0% to $112M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $2M since the same quarter in the previous year.
Finally, its free cash flow grew by 77.6% to $21M since the same quarter in the previous year.
Based on the above factors, CVS Group plc gets an overall score of 3/5.